If you or someone you know uses Primatene or any other over-the-counter epinephrine inhaler for asthma, the clock is officially ticking before they disappear off store shelves. The Food and Drug Administration announced today that, in an effort to cut down on products using ozone-depleting chlorofluorocarbons, these inhalers will no longer be available after Dec. 31.
More »
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
2 comments:
Every asthmatic knows this is just another scam by the drug company.
My old inhaler cost $5.
The new inhaler now costs $30 and does not work as effectively as the old one did.
Just another case of big drug in the pocket of the FDA and the only one losing are the patients.
6:42
The EPA banned it because of junk science about ozone.
Post a Comment